IP Library › Granted Patent US 11,213,513
Granted Patent B2
US 11,213,513 · App. 16/488,451 · Granted Jan 4, 2022

Compositions and methods for promoting hair growth with Mpc1 inhibitors

Inventors: William E. Lowry (Los Angeles, CA); Heather R. Christofk (Los Angeles, CA); Aimee Flores (Los Angeles, CA)
Assignee: The Regents of the University of California
A61K31/405A61K8/492A61K9/0014A61K9/107A61P17/14A61Q7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,213,513
App. No.
16/488,451
Granted
Jan 4, 2022
Kind
B2
Abstract

Provided herein are methods of accelerating, promoting, or restoring hair growth, comprising administering to a subject in need thereof an effective amount of a compound of formula (I). Also provided are compositions comprising the compound of formula (I).

Claims (21)

1. A method of accelerating, promoting, or restoring hair growth, comprising administering to a subject in need thereof an effective amount of a compound of formula (I):

or a pharmaceutically acceptable salt thereof.

2. The method of claim 1 , wherein administering comprises topically applying a composition comprising the compound to an affected area.

3. The method of claim 1 , wherein the subject exhibits symptoms selected from alopecia, hair loss, hair thinning, and baldness.

4. The method of claim 1 , wherein the subject exhibits symptoms selected from hair loss, hair thinning, and baldness.

5. The method of claim 1 , wherein the subject exhibits baldness.

6. The method of claim 5 , wherein the baldness is male pattern baldness or female pattern baldness.

7. The method of claim 1 , wherein the subject exhibits symptoms selected from hair loss and hair thinning.

8. The method of claim 7 , wherein the hair loss or the hair thinning is caused by anagen effluvium or telogen effluvium.

9. The method of claim 3 , wherein the alopecia is selected from juvenile alopecia, premature alopecia, senile alopecia, alopecia areata, androgenic alopecia, mechanical alopecia, and symptomatic alopecia.

10. The method of claim 1 , wherein the compound is applied to a hair follicle.

11. The method of claim 1 , wherein the compound of formula (I) is administered daily.

12. The method of claim 1 , wherein the subject is a mammal.

13. The method of claim 1 , wherein the subject is a human.

14. The method of claim 1 , wherein: administering comprises topically applying a composition comprising the compound to an affected area; the subject exhibits symptoms selected from alopecia, hair loss, hair thinning, and baldness; and the subject is human.

15. The method of claim 14 , wherein the subject exhibits symptoms of baldness.

16. The method of claim 15 , wherein the baldness is male pattern baldness or female pattern baldness.

17. The method of claim 14 , wherein the subject exhibits symptoms of alopecia.

18. The method of claim 17 , wherein the alopecia is selected from juvenile alopecia, premature alopecia, senile alopecia, alopecia areata, androgenic alopecia, mechanical alopecia, and symptomatic alopecia.

19. The method of claim 14 , wherein the subject exhibits symptoms selected from hair loss and hair thinning.

20. The method of claim 19 , wherein the hair loss or the hair thinning is caused by anagen effluvium or telogen effluvium.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2021
From: FLORES, AIMEE
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 057024/0541 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2019
From: LOWRY, WILLIAM E.; CHRISTOFK, HEATHER R.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 050185/0293 →
Continuity (2)
Provisional Application 62463232 · Feb 24, 2017
Related Publication 20200030289A1 · Jan 30, 2020
Cited By (3)
US 12,227,503 US 12,559,490 US 12,649,736